Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.63 USD | -1.99% | +5.04% | -13.02% |
07/05 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
07/05 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.02% | 1.9B | |
+33.42% | 49.46B | |
+1.76% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.82% | 26.61B | |
-22.12% | 18.64B | |
+7.80% | 13.16B | |
+29.37% | 12.55B | |
+23.72% | 12.1B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- BMO Capital Upgrades Beam Therapeutics to Outperform From Market Perform, Raises Price Target to $66 From $61